🎉 M&A multiples are live!
Check it out!

Fortrea Valuation Multiples

Discover revenue and EBITDA valuation multiples for Fortrea and similar public comparables like Suven Pharma, Dishman Carbogen Amics, and Syngene International.

Fortrea Overview

About Fortrea

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.


Founded

2023

HQ

United States of America
Employees

15.5K+

Website

fortrea.com

Financials

LTM Revenue $2.6B

LTM EBITDA $197M

EV

$1.6B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Fortrea Financials

Fortrea has a last 12-month revenue of $2.6B and a last 12-month EBITDA of $197M.

In the most recent fiscal year, Fortrea achieved revenue of $2.7B and an EBITDA of -$64.3M.

Fortrea expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Fortrea valuation multiples based on analyst estimates

Fortrea P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $3.1B $2.7B XXX XXX XXX
Gross Profit $622M $520M XXX XXX XXX
Gross Margin 20% 19% XXX XXX XXX
EBITDA $167M -$64.3M XXX XXX XXX
EBITDA Margin 5% -2% XXX XXX XXX
Net Profit $58.4M -$3.4M XXX XXX XXX
Net Margin 2% 0% XXX XXX XXX
Net Debt n/a $1.5B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Fortrea Stock Performance

As of April 15, 2025, Fortrea's stock price is $5.

Fortrea has current market cap of $483M, and EV of $1.6B.

See Fortrea trading valuation data

Fortrea Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.6B $483M XXX XXX XXX XXX $0.36

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Fortrea Valuation Multiples

As of April 15, 2025, Fortrea has market cap of $483M and EV of $1.6B.

Fortrea's trades at 0.6x LTM EV/Revenue multiple, and 7.9x LTM EBITDA.

Analysts estimate Fortrea's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Fortrea and 10K+ public comps

Fortrea Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.6B XXX XXX XXX
EV/Revenue 0.6x XXX XXX XXX
EV/EBITDA -24.3x XXX XXX XXX
P/E -1.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 6.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Fortrea Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Fortrea Valuation Multiples

Fortrea's NTM/LTM revenue growth is -5%

Fortrea's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $42K for the same period.

Over next 12 months, Fortrea's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Fortrea's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Fortrea and other 10K+ public comps

Fortrea Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -13% XXX XXX XXX XXX
EBITDA Margin -2% XXX XXX XXX XXX
EBITDA Growth -138% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -7% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $42K XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 24% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Fortrea Public Comps

See public comps and valuation multiples for Contract Research & Manufacturing comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Jubilant Pharmova XXX XXX XXX XXX XXX XXX
Biocon XXX XXX XXX XXX XXX XXX
Syngene International XXX XXX XXX XXX XXX XXX
Dishman Carbogen Amics XXX XXX XXX XXX XXX XXX
Suven Pharma XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Fortrea M&A and Investment Activity

Fortrea acquired  XXX companies to date.

Last acquisition by Fortrea was  XXXXXXXX, XXXXX XXXXX XXXXXX . Fortrea acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Fortrea

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Fortrea

When was Fortrea founded? Fortrea was founded in 2023.
Where is Fortrea headquartered? Fortrea is headquartered in United States of America.
How many employees does Fortrea have? As of today, Fortrea has 15.5K+ employees.
Who is the CEO of Fortrea? Fortrea's CEO is Mr. Thomas H. Pike.
Is Fortrea publicy listed? Yes, Fortrea is a public company listed on NAS.
What is the stock symbol of Fortrea? Fortrea trades under FTRE ticker.
When did Fortrea go public? Fortrea went public in 2023.
Who are competitors of Fortrea? Similar companies to Fortrea include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics.
What is the current market cap of Fortrea? Fortrea's current market cap is $483M
What is the current revenue of Fortrea? Fortrea's last 12-month revenue is $2.6B.
What is the current EBITDA of Fortrea? Fortrea's last 12-month EBITDA is $197M.
What is the current EV/Revenue multiple of Fortrea? Current revenue multiple of Fortrea is 0.6x.
What is the current EV/EBITDA multiple of Fortrea? Current EBITDA multiple of Fortrea is 7.9x.
What is the current revenue growth of Fortrea? Fortrea revenue growth between 2023 and 2024 was -13%.
Is Fortrea profitable? Yes, Fortrea is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.